Share This

 

Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.

 

Oertli, the winner of the Swiss Medtech Award 2024, proudly accepts the prize.

 

The Swiss Medtech Award, established in 2018, has become one of the most important awards in the Swiss medical technology sector. This prestigious innovation award recognizes outstanding achievements in the Swiss medical technology industry.

The jury, chaired by ETH Prof. Mirko Meboldt, evaluates the candidates based on the criteria of patient benefit, contribution to improving healthcare and technological pioneering spirit. Oertli Instrumente AG from Berneck, Switzerland, impressed the jury not only with the criteria mentioned, but also with its consistent Swiss quality mindset, focus on core processes and interdisciplinarity.

At the Swiss Medtech Day (11 June 2024) in Bern, in front of over 700 representatives of the Swiss medtech industry, the two brothers Christoph and Thomas Bosshard, Co-CEOs of the family-run company, proudly accepted the coveted award.

“We are extremely proud to have won the Swiss Medtech Award 2024,” said the Bosshard brothers. "This award is a testament of the competent and professional work and dedication of our entire company. This recognition motivates us to remain at the forefront of the medical technology industry and to develop pioneering innovations to meet the challenges in the healthcare sector. We are delighted to celebrate this award together with our employees".

Products developed and manufactured under one roof at Oertli are used worldwide in cataract, glaucoma and retinal surgery. The approximately 300 employees at the headquarters in Berneck, along with 120 employees from five subsidiaries, give their best every day so that doctors and surgical staff can operate safely, easily and efficiently.

Oertli develops, manufactures and markets surgical platforms, instruments and consumables that enables surgeons and OR personnel to perform cataract, glaucoma and vitreoretinal surgeries easier, safer and more efficient, thus achieving better results for their patients. With innovative developments and first-class quality, Oertli has constantly set new standards since 1955. The family-owned company develops and produces exclusively in Switzerland in the St.Gallen Rhine Valley. Oertli – Making the difference in eye surgery.

 

FURTHER INFORMATION:

www.oertli-instruments.com

Share This